Log in to your Inderes Free account to see all free content on this page.
Zealand Pharma
318.00 DKK
+0.98 %
Less than 1K followers
ZEAL
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+0.98 %
+5.72 %
-19.06 %
-31.82 %
-39.06 %
-26.08 %
+19.64 %
+65.02 %
+300.00 %
Zealand Pharma operates in biotechnology. Special focus is found in the development of drugs for the treatment of diabetes and various intestinal diseases. The company has a varied product portfolio with separate brands that are sold on a global level. The largest operations are in the Nordic market. Zealand Pharma was founded in 1997 and is headquartered in Søborg, Denmark.
Read moreMarket cap
22.75B DKK
Turnover
76.72M DKK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26.5.
2026
Extraordinary general meeting '26
13.8.
2026
Interim report Q2'26
12.11.
2026
Interim report Q3'26
All
Press releases
ShowingAll content types
Zealand Pharma - Execution framework for share buy-back program
Zealand Pharma Announces Financial Results for the First Three Months of 2026
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio